Cyclin-dependent kinase 4/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib

被引：0
|
作者：
Dorota Kwapisz
机构：
[1] Specialist Outpatient Clinic,
来源：
Breast Cancer Research and Treatment | 2017年 / 166卷
关键词：
CDK4/6 inhibitors; Breast cancer; Palbociclib; Ribociclib; Abemaciclib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：41 / 54
页数：13
相关论文
共 50 条
  • [1] Cyclin-dependent kinase 4/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib
    Kwapisz, Dorota
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (01) : 41 - 54
  • [2] Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib
    Groenland, Stefanie L.
    Martinez-Chavez, Alejandra
    van Dongen, Marloes G. J.
    Beijnen, Jos H.
    Schinkel, Alfred H.
    Huitema, Alwin D. R.
    Steeghs, Neeltje
    [J]. CLINICAL PHARMACOKINETICS, 2020, 59 (12) : 1501 - 1520
  • [3] Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib
    Stefanie L. Groenland
    Alejandra Martínez-Chávez
    Marloes G. J. van Dongen
    Jos H. Beijnen
    Alfred H. Schinkel
    Alwin D. R. Huitema
    Neeltje Steeghs
    [J]. Clinical Pharmacokinetics, 2020, 59 : 1501 - 1520
  • [4] Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment
    Iuliani, Michele
    Simonetti, Sonia
    Ribelli, Giulia
    Napolitano, Andrea
    Longo, Umile Giuseppe
    Vincenzi, Bruno
    Orsaria, Paolo
    Denaro, Vincenzo
    Tonini, Giuseppe
    Santini, Daniele
    Francesco, Pantano
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [5] Differences of cyclin-dependent kinase 4/6 inhibitor, palbociclib and abemaciclib, in breast cancer
    Tamura, Kenji
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (11) : 993 - 998
  • [6] Cyclin-dependent kinase 4/6 inhibitors palbociclib or ribociclib combined with endocrine therapy and radiation therapy for patients with metastatic breast cancer
    Ratosa, I.
    Scoccimarro, E.
    Dominici, L.
    Orazem, M.
    Steinacher, M.
    Aquilano, M.
    Cerbai, C.
    Desideri, I.
    Marinko, T.
    Livi, L.
    Meattini, I.
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 138 : S66 - S66
  • [7] Cyclin-Dependent Kinase 4/6 Inhibitors Against Breast Cancer
    Hassan, Mohammed Al-Kassim
    Ates-Alagoz, Zeynep
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2023, 23 (04) : 412 - 428
  • [8] Cyclin-dependent kinase 4/6 inhibitors in breast cancer therapy
    Migliaccio, Ilenia
    Di Leo, Angelo
    Malorni, Luca
    [J]. CURRENT OPINION IN ONCOLOGY, 2014, 26 (06) : 568 - 575
  • [9] CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and Abemaciclib
    Eggersmann, Tanja K.
    Degenhardt, Tom
    Gluz, Oleg
    Wuerstlein, Rachel
    Harbeck, Nadia
    [J]. BIODRUGS, 2019, 33 (02) : 125 - 135
  • [10] CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and Abemaciclib
    Tanja K. Eggersmann
    Tom Degenhardt
    Oleg Gluz
    Rachel Wuerstlein
    Nadia Harbeck
    [J]. BioDrugs, 2019, 33 : 125 - 135
12345